The global market for Regenerative Gene Therapy for Metabolic Disorders is entering a period of transformative growth, driven by breakthrough advancements in gene editing technologies and a rising demand for curative, single-administration treatments. Metabolic disorders, many of which are severe, rare, and life-threatening inherited conditions (such as Lysosomal Storage Diseases and ... https://www.databridgemarketresearch.com/